Product Information

TAZAROTENE 0.05% CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $8.0046 per GM under NDC 45802070696. Its NADAC has been published 79 times since Feb 19, 2025.

FDA first approved this application on Jul 15, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TAZAROTENE 0.05% CREAM

tazarotene
$8.0046per GM

Strength

.5 mg/g

NDC

45802070696

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

TAZAROTENE

Approval Type

Generic (ANDA)

FDA Application

ANDA217075

FDA Approved

7/15/2024

TE Code

AB

On Market Since

9/9/2024

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for TAZAROTENE 0.05% CREAM has been published 79 times since Feb 19, 2025, and over the history we have for it it has declined 30.1%. The table below summarizes its recorded NADAC range and movement.

Current price$8.0046 per GM
All-time high$11.6095 (Jun 11, 2025)
All-time low$8.0046 (Aug 19, 2026)
52-week high$11.0233
52-week low$8.0046
Median price$10.2350
Average price$10.2837
Largest weekly change-14.6% (Jun 17, 2026)
Weeks tracked79
Tracking sinceFeb 19, 2025

Price History

1W

-3.5%

1M

-3.5%

3M

-19.3%

6M

-21.8%

1Y

-24.9%

3Y

N/A

5Y

N/A

All

-30.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tazarotene market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of TAZAROTENE 0.05% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.05% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $8.0046 per GM (NDC 45802070696), effective Aug 19, 2026.

How has the price of TAZAROTENE 0.05% CREAM changed over time?

Over the history we have for it, the NADAC for TAZAROTENE 0.05% CREAM has declined 30.1%. It has been tracked across 79 weekly CMS publications since Feb 19, 2025.

What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.05% CREAM?

Since Feb 19, 2025, the NADAC for TAZAROTENE 0.05% CREAM has ranged from a low of $8.0046 (Aug 19, 2026) to a high of $11.6095 (Jun 11, 2025), with a median of $10.2350 per GM.

Are there cheaper alternatives to TAZAROTENE 0.05% CREAM?

No other NADAC-published product currently shares the active ingredient and strength of TAZAROTENE 0.05% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TAZAROTENE 0.05% CREAM?

TAZAROTENE 0.05% CREAM (NDC 45802070696) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.